|
Significant components of the Company's deferred tax assets and liabilities as follows (Details) (USD $)
|
Dec. 31, 2013
|
Dec. 31, 2012
|
| Significant components of the Company's deferred tax assets and liabilities as follows |
|
|
| Intangible assets |
$ 59,000 |
$ 130,000 |
| Deferred revenue |
3,425,000 |
2,779,000 |
| Other reserves and accruals |
1,253,000 |
1,621,000 |
| Tax credit carryforwards |
0 |
0 |
| Property, plant and equipment |
1,450,000 |
1,541,000 |
| Amortization of stock-based compensation |
9,183,000 |
8,495,000 |
| Capitalized research & development expenditures |
13,775,000 |
15,846,000 |
| Net operating loss carryforwards |
9,883,000 |
3,347,000 |
| Total deferred tax asset |
39,028,000 |
33,759,000 |
| Valuation allowance |
(26,746,000) |
(17,001,000) |
| Net deferred tax assets |
12,282,000 |
16,758,000 |
| Non-employee stock based compensation |
(1,556,000) |
(1,556,000) |
| Section 382 recognized built in loss |
(10,726,000) |
(15,202,000) |
| Net deferred tax liability |
(12,282,000) |
(16,758,000) |
| Net |
0 |
0 |
| Intangible assets |
999,000 |
694,000 |
| Deferred revenue |
0 |
0 |
| Other reserves and accruals |
0 |
0 |
| Tax credit carryforwards |
84,000 |
1,569,000 |
| Property, plant and equipment |
504,000 |
541,000 |
| Amortization of stock-based compensation |
0 |
0 |
| Capitalized research & development expenditures |
5,195,000 |
5,384,000 |
| Net operating loss carryforwards |
3,556,000 |
3,541,000 |
| Total deferred tax asset |
10,338,000 |
11,729,000 |
| Valuation allowance |
(10,338,000) |
(11,729,000) |
| Net deferred tax assets |
0 |
0 |
| Non-employee stock based compensation |
0 |
0 |
| Section 382 recognized built in loss |
0 |
0 |
| Net deferred tax liability |
0 |
0 |
| Net |
$ 0 |
$ 0 |